Author:
Van Belle S. J. P.,de Planque M. M.,Smith I. E.,van Oosterom A. T.,Schoemaker T. J.,Deneve W.,McVie J. G.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference26 articles.
1. Alberts DS, Griffiths KS, Goodman GE, Herman TS, Murray E (1980) Phase I clinical trial of mitoxantrone: a new anthracenedione anticancer drug. Cancer Chemother Pharmacol 5: 11
2. Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL (1983) Disposition of mitoxantrone in patients. Cancer Treat Rev 10 [Suppl B]: 23
3. Bowden GT, Peng YM, Alberts DS (1984) Comparative molecular pharmacology of the anthracene anticancer drugs bisantrene and mitoxantrone. Proc Am Assoc Cancer Res 75: 1171
4. Chiccarelli FS, Morrison JA, Gautam SR (1984) Biliary pharmacokinetics of c14-Mitoxantrone in the rat following different intravenous doses and characteristics of drug-related material in the bile. Fed Proc 43(3): 345
5. Coltman CA JR, McDaniel TM, Balcerzak SP, Morrison FS, von Hoff DD (1983) Mitoxantrone hydrochloride (NSC-310739) in lymphoma. Invest New Drugs 1: 65
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献